Quantcast

Latest depression Stories

depression brain molecule
2014-06-09 04:40:57

redOrbit Staff & Wire Reports - Your Universe Online Levels of a tiny molecule known as miR-1202 are lower in the brains of people suffering from depression, suggesting that it could serve as a marker for depression and help detect which patients are most likely to respond to antidepressant treatment, experts from McGill University and the Douglas Institute claim in a new study. Their research, which has been published by the journal Nature Medicine, shows that miR-1202 could...

2014-06-06 23:00:26

‘Out of the Darkness’ expresses experience with Bipolar disorder, shares hope for others so-afflicted. Boca Raton, Fla. (PRWEB) June 07, 2014 Author Timothy Mahfood spent many years of his young life in the dark. Not a literal darkness due to lack of sight, a darkness of depression due to Bipolar disorder. He commends his grandfather for inspiring him to come out of the darkness of his illness and now hopes to pass his grandfather’s coaching words on to others. The new book, “Out...

2014-06-05 23:16:23

Charter Fitness of New Lenox is partnering with Joliet Junior College Nursing students to provide the tools necessary to enhance physical and mental well-being of patients with anxiety, bipolar disorder and depression. It is known that exercise has physical benefits, and its effect as a weapon against depression and other mental health conditions is substantial. New Lenox, IL (PRWEB) June 05, 2014 Charter Fitness of New Lenox is partnering with Joliet Junior College Nursing students to...

2014-06-05 13:23:31

The JAMA Network Journals Bottom Line: Major depressive disorder (MDD) with atypical features (including mood reactivity where people can feel better when positive things happen in life, increased appetite or weight gain) appears to be associated with obesity. Authors: Aurélie M. Lasserre, M.D., of Lausanne University Hospital, Switzerland, and colleagues. Background: MDD has tremendous public health impact worldwide. Obesity is another burden for public health. Understanding the...

2014-06-03 08:31:20

LOS ANGELES, June 03, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced that Ian A. Cook, M.D., has joined NeuroSigma on June 1, 2014 as Chief Medical Officer and Senior Vice President. Dr. Cook is a physician and bioengineer who has been an innovator in medical therapeutics and...

BRAIN Initiative Gains Momentum In Anxiety, Depression Research
2014-05-29 13:24:31

[ Watch the Video: Untangling The Brain Circuits In Mental Illness ] Alan McStravick for redorbit.com - Your Universe online Just over a year ago, the White House announced a new initiative aimed at gaining a broader understanding of how the human brain works. The BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative will present new and novel ways to treat, prevent and cure brain disorders like Alzheimer's, schizophrenia, autism, epilepsy and traumatic brain...

2014-05-23 16:23:50

BERKELEY, Calif., May 23, 2014 /PRNewswire-iReach/ -- Diapression - Connect with help. (Logo: http://photos.prnewswire.com/prnh/20140522/90764) In recognition of Mental Health Awareness Month, Diabetes Advocates, a program of the Diabetes Hands Foundation, calls for greater patient attention to the relationship between diabetes and depression. Diabetes Advocates agrees with the opening sentence in a 2010 article in the Patient Education and Counseling: "There is an urgent need for more...

2014-05-23 12:24:31

GERMANTOWN, Md., May 23, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that data from the NSI-189 Phase Ib study in major depressive disorder (MDD) will be presented at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Florida, on June 17th at 4:15 EDT. NSI-189 is Neuralstem's first-in-class, lead neurogenic small molecule compound. In pre-clinical studies, NSI-189 was shown to promote the formation of new neurons (neurogenesis) in...

2014-05-06 16:32:06

Companion health economics analysis shows Transcranial Magnetic Stimulation (TMS) is cost-effective among patients who fail to benefit from prior antidepressant medication NEW YORK, May 6, 2014 /PRNewswire/ -- Neuronetics, Inc. announced today a new analysis of data at the annual meeting of the American Psychiatric Association that shows Transcranial Magnetic Stimulation (TMS) administered with the NeuroStar TMS Therapy System resulted in greater symptom improvement than next-choice...

2014-05-06 16:26:53

CARDIFF, Calif., May 6, 2014 /PRNewswire/ -- NI Research has released the May issue of NeuroPerspective, which features a comprehensive review of pharmacotherapies for depression, with a particular focus upon the companies developing RAADs, rapid-acting antidepressants, an approach that springs from the reports of accelerated depression relief via the use of ketamine, and has been further invigorated by the success of Naurex's GlyX-13 in clinical testing. As NeuroPerspective publisher Harry...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related